Biosim's mission is to revolutionize drug discovery by integrating AI and quantum chemistry to drastically shorten project timelines from years to weeks. The company focuses on small-molecule drug discovery, leveraging advanced scientific computing to expedite the development process. Founded by Garegin Papoian, a Monroe Martin Professor of Chemistry at the University of Maryland, Biosim aims to transform the pharmaceutical industry with its innovative platform.
Biosim has made significant strides in accelerating drug discovery, reducing the timescale of projects and enhancing efficiency. The company has established a world-class R&D team under the leadership of Garegin Papoian, contributing to its growing impact in the field. By combining cutting-edge technologies, Biosim is poised to become a key player in the pharmaceutical industry, driving advancements and fostering innovation.
